The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE
The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE
Recruiting · NCT07185269 · Registry updated 2025-11-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Phase 1 / Phase 2 | 2025-11-26 | NCT07185269 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 18 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking Union Medical College Hospital | Beijing | China | 201 |